| Jeffrey Francis Perry, OTR/L | |
|
8100 S Walker Ave, Bldg B, Oklahoma City, OK 73139-9402 | |
| (405) 602-6565 | |
| Not Available |
| Full Name | Jeffrey Francis Perry |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapist |
| Location | 8100 S Walker Ave, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265498679 | NPI | - | NPPES |
| OT523 | Other | OK | OCCUPATIONAL THERAPIST |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT 523 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Francis Perry, OTR/L 3408 Abilene Cir, Norman, OK 73072-2904 Ph: (405) 579-4204 | Jeffrey Francis Perry, OTR/L 8100 S Walker Ave, Bldg B, Oklahoma City, OK 73139-9402 Ph: (405) 602-6565 |
News Archive
Rigel Medical has supplied medical test equipment to a global charity which delivers healthcare services onboard the world's largest private hospital ship.
BioInvent International AB and ThromboGenics NV announce today positive results from their Phase II trial of TB-402. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism following orthopaedic surgery.
In what is seen as a major split with the United States over the AIDS pandemic, Europe, led by the UK, is tacitly urging African governments not to listen to the abstinence-focused agenda of the Bush administration.
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced that Dr. David B. Weiner, Chairman of Inovio's Scientific Advisory Board, highlighted advances in electroporation-delivered SynCon™ DNA vaccines compared to other leading vaccine technologies at the AIDS Vaccine 2009 Conference being held this week in Paris, France.
VIVUS, Inc. announced today that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for the investigational new drug QNEXA® (phentermine/topiramate) Controlled-Release Capsules. The FDA issued the CRL to communicate its decision that the NDA cannot be approved in its present form.
› Verified 4 days ago
Jovan Pride, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5701 Se 74th St Ste G, Oklahoma City, OK 73135 Phone: 405-610-1909 Fax: 405-610-1910 | |
Tung Le, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3327 Nw 50th St, Oklahoma City, OK 73112 Phone: 405-946-7300 | |
Dr. Rachele Quinones, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6525 N Meridian Ave, Ste, Oklahoma City, OK 73116 Phone: 405-721-1115 | |
Keli A Boone, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1404 Nw 122nd St, Oklahoma City, OK 73114 Phone: 405-749-8131 | |
Caroline Jean Grubbs, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6400 N Santa Fe Ave, Suite B, Oklahoma City, OK 73116 Phone: 405-840-2903 Fax: 405-840-3256 | |
Ms. Denise Lashaun Shaw, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2828 Nw 57th St Ste 302, Oklahoma City, OK 73112 Phone: 405-840-1253 | |
Kallie Kim, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4220 Se 34th St, Oklahoma City, OK 73165 Phone: 785-213-1894 |